ExamVeda
Login
Home

Current Affairs 4th February, 2016

Administrator Feb 04, 2016 2016 0 comments
Share this article

National

CSIR launches India’s first ayurvedic anti-diabetic drug named BGR-34

The Council for Scientific and Industrial Research (CSIR) has launched the country’s first anti-diabetic ayurvedic drug named BGR-34 for type two Diabetes mellitus.………Read More

Bharat Biotech develops world’s first Zika vaccine candidates

Hyderabad-based vaccines manufacturer Bharat Biotech has announced a breakthrough in developing the world’s first Zika vaccine by developing two candidates..………Read More

Maharashtra announces Babasaheb Ambedkar Special Group Incentives Scheme

Maharashtra government has announced Bharatratna Dr. Babasaheb Ambedkar Special Collective Incentive Scheme for the economically backward Dalit entrepreneurs. .………Read More

International

12 nations sign historic Trans-Pacific Partnership (TPP) Agreement

All 12 Pacific Rim countries have signed Trans-Pacific Partnership (TPP) agreement in Auckland, New Zealand making it one of the biggest trade deals in history. .………Read More

New Appointments

DJ Pandian appointed AIIB Vice-President

Former IAS officer D J Pandian has been appointed vice-president and chief investment officer (CIO) of Beijing-based Asian Infrastructure Investment Bank (AIIB). .………Read More

Business and Economy

Union Government sets up two committees to ensure consistency in tax policies

The Union Government has constituted two new committees namely Tax Policy Research Unit (TPRU) and Tax Policy Council (TPC) to streamline the taxation policy and administration..………Read More

Sports

Kerala wins 61st National School Athletics championship

Kerala has won the 61st National School Athletics championship which concluded in Kozhikode. With this, Kerala (host) become champions in the event for the 19th consecutive time. .………Read More

Current Affairs: 3rd February, 2016
Current Affairs questions and answers, January, 2016

Share with your Friends

Help others discover this useful content.

Join The Discussion

Have something to add? Share your thoughts.

Comments 0

Discussion from ExamVeda readers.
Be the first one to review. Share your thoughts about this topic.